Latest Price Targets from the World's Best Analysts & Research Firms

Analyst & Firm Stock Price Price Target Upside
Downside
Rating Date
KB&W
11476
Keefe, Bruyette & Woods
Jade Rahmani
LEN icon
Lennar Class A
LEN
$35.4B
$136.58 $114
17%
downside
Market Perform 20 Jun ‘25
2 months ago
RC
11477
Roth Capital
Sean McGowan
GRPN icon
Groupon
GRPN
$916M
$22.67 $47
107%
upside
Buy 20 Jun ‘25
2 months ago
RC
11478
Roth Capital
Scott Searle
ADEA icon
Adeia
ADEA
$1.65B
$15.11 $26
72%
upside
Buy 20 Jun ‘25
2 months ago
BRS
11479
B. Riley Securities
Matt Howlett
ONIT
Onity Group Inc.
ONIT
$352M
$43.72 $55
26%
upside
Buy 20 Jun ‘25
2 months ago
PR
11480
Pivotal Research
Jeffrey Wlodarczak
NFLX icon
Netflix
NFLX
$530B
$1,247.71 $1,600
28%
upside
Buy 20 Jun ‘25
2 months ago
DB
11481
Deutsche Bank
Krisztina Katai
NKE icon
Nike
NKE
$110B
$74.25 $71
4%
downside
Buy 20 Jun ‘25
2 months ago
BOAS
11482
B of A Securities
Ruplu Bhattacharya
JBL icon
Jabil
JBL
$23.2B
$215.72 $245
14%
upside
Buy 20 Jun ‘25
2 months ago
BOAS
11483
B of A Securities
Joseph Tumillo
KNSL icon
Kinsale Capital Group
KNSL
$9.92B
$425.66 $543
28%
upside
Buy 20 Jun ‘25
2 months ago
JM
11484
JP Morgan
Paul Coster
ARRY icon
Array Technologies
ARRY
$1.25B
$8.19 $13
59%
upside
Overweight 20 Jun ‘25
2 months ago
RC
11485
RBC Capital
Leonid Timashev
CRMD icon
CorMedix
CRMD
$955M
$12.79 $17
33%
upside
Outperform 20 Jun ‘25
2 months ago
DD
11486
DA Davidson
Gil Luria
NICE icon
Nice
NICE
$8.77B
$142.03 $195
37%
upside
Buy 20 Jun ‘25
2 months ago
RC
11487
RBC Capital
Leonid Timashev
ADCT icon
ADC Therapeutics
ADCT
$363M
$3.23 $5
55%
upside
Outperform 20 Jun ‘25
2 months ago
G
11488
Guggenheim
Debjit Chattopadhyay
RARE icon
Ultragenyx Pharmaceutical
RARE
$3.02B
$31.29 $64
105%
upside
Buy 20 Jun ‘25
2 months ago
JS
11489
JMP Securities
Aaron Hecht
LEN icon
Lennar Class A
LEN
$35.4B
$136.58 $130
5%
downside
Market Outperform 20 Jun ‘25
2 months ago
B
11490
Baird
Craig Kennison
PATK icon
Patrick Industries
PATK
$3.72B
$111.65 $90
19%
downside
Neutral 20 Jun ‘25
2 months ago
JS
11491
JMP Securities
Constantine Davides
EVH icon
Evolent Health
EVH
$1.07B
$9.19 $13
41%
upside
Market Outperform 20 Jun ‘25
2 months ago
W
11492
Wedbush
Daniel Ives
NICE icon
Nice
NICE
$8.77B
$142.03 $200
41%
upside
Outperform 20 Jun ‘25
2 months ago
WF
11493
Wells Fargo
Michael Blum
ARRY icon
Array Technologies
ARRY
$1.25B
$8.19 $8
2%
downside
Equal-Weight 20 Jun ‘25
2 months ago
W
11494
Wedbush
Robert Driscoll
KURA icon
Kura Oncology
KURA
$709M
$8.17 $36
341%
upside
Outperform 20 Jun ‘25
2 months ago
WF
11495
Wells Fargo
Derek Archila
ATYR
aTyr Pharma
ATYR
$513M
$5.24 $25
377%
upside
Overweight 20 Jun ‘25
2 months ago
W
11496
Wedbush
Jay McCanless
BLDR icon
Builders FirstSource
BLDR
$15.5B
$140.25 $145
3%
upside
Outperform 20 Jun ‘25
2 months ago
B
11497
Barclays
David Anderson
HP icon
Helmerich & Payne
HP
$2.07B
$20.86 $17
19%
downside
Equal-Weight 20 Jun ‘25
2 months ago
W
11498
Wedbush
Daniel Ives
IBM icon
IBM
IBM
$239B
$256.88 $325
27%
upside
Outperform 20 Jun ‘25
2 months ago
C
11499
CICC
SNOW icon
Snowflake
SNOW
$76.5B
$225.85 $225
0%
downside
Outperform 20 Jun ‘25
2 months ago
WR
11500
Wolfe Research
Steven Chubak
TPG icon
TPG
TPG
$8.85B
$59.97 $60
0%
upside
Outperform 20 Jun ‘25
2 months ago